The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors

Cannabis and Psychedelics

October 31, 2024

Buy ($175)

Companies covered: COMPASS Pathways PLC (NASDAQ:CMPS), Mind Medicine (MindMed) Inc. (NASDAQ:MNMD), GH Research PLC (NASDAQ:GHRS), Cybin Inc. (NYSEAMERICAN:CYBN), ATAI Life Sciences NV (NASDAQ:ATAI), BetterLife Pharma Inc. (OTCMKTS:BETRF), Cansortium Inc. (OTCMKTS:CNTMF), Greenlane Holdings Inc. (NASDAQ:GNLN), Planet 13 Holdings Inc. (OTCMKTS:PLNH)

Five Companies Dominate in Psychedelics-Based Drug Development
Patrick R. Trucchio
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Ahmad Doroudian
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
Robert Beasley
Interview with the CEO: Greenlane Holdings, Inc. (NASDAQ:GNLN)
Barbara Sher
Interview with the Co-CEO and the CAO: Planet 13 Holdings Inc. (OTCMKTS:PLNH)
Robert Groesbeck;  Lee Fraser
Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
AI Opportunities Expand to Industrial, Utilities and Energy Sectors
India Fund Manager Expects Discretionary Spending to Grow
Inefficiency in Ex-US Markets Creates Opportunity to Buy at a Discount
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy